These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 35778876)

  • 1. Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.
    Khokhar D; Marella S; Idelman G; Chang JW; Chehade M; Hogan SP
    Clin Exp Allergy; 2022 Oct; 52(10):1142-1156. PubMed ID: 35778876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis.
    Vanoni S; Zeng C; Marella S; Uddin J; Wu D; Arora K; Ptaschinski C; Que J; Noah T; Waggoner L; Barski A; Kartashov A; Rochman M; Wen T; Martin L; Spence J; Collins M; Mukkada V; Putnam P; Naren A; Chehade M; Rothenberg ME; Hogan SP
    J Allergy Clin Immunol; 2020 Jan; 145(1):239-254.e2. PubMed ID: 31647967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis.
    Marella S; Sharma A; Ganesan V; Ferrer-Torres D; Krempski JW; Idelman G; Clark S; Nasiri Z; Vanoni S; Zeng C; Dlugosz AA; Zhou H; Wang S; Doyle AD; Wright BL; Spence JR; Chehade M; Hogan SP
    J Allergy Clin Immunol; 2023 Dec; 152(6):1550-1568. PubMed ID: 37652141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.
    Zeng C; Vanoni S; Wu D; Caldwell JM; Wheeler JC; Arora K; Noah TK; Waggoner L; Besse JA; Yamani AN; Uddin J; Rochman M; Wen T; Chehade M; Collins MH; Mukkada VA; Putnam PE; Naren AP; Rothenberg ME; Hogan SP
    J Allergy Clin Immunol; 2018 Dec; 142(6):1843-1855. PubMed ID: 29729938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain-14 and its association with eosinophilic esophagitis.
    Litosh VA; Rochman M; Rymer JK; Porollo A; Kottyan LC; Rothenberg ME
    J Allergy Clin Immunol; 2017 Jun; 139(6):1762-1771.e7. PubMed ID: 28131390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis.
    Simon D; Page B; Vogel M; Bussmann C; Blanchard C; Straumann A; Simon HU
    Allergy; 2018 Jan; 73(1):239-247. PubMed ID: 28712126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRC31 is induced by IL-13 and regulates kallikrein expression and barrier function in the esophageal epithelium.
    D'Mello RJ; Caldwell JM; Azouz NP; Wen T; Sherrill JD; Hogan SP; Rothenberg ME
    Mucosal Immunol; 2016 May; 9(3):744-56. PubMed ID: 26462420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue remodeling in eosinophilic esophagitis.
    Cheng E; Souza RF; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1175-87. PubMed ID: 23019192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic, Inflammatory, and Epithelial Cell Differentiation Factors Control Expression of Human Calpain-14.
    Miller DE; Forney C; Rochman M; Cranert S; Habel J; Rymer J; Lynch A; Schroeder C; Lee J; Sauder A; Smith Q; Chawla M; Trimarchi MP; Lu X; Fjellman E; Brusilovsky M; Barski A; Waggoner S; Weirauch MT; Rothenberg ME; Kottyan LC
    G3 (Bethesda); 2019 Mar; 9(3):729-736. PubMed ID: 30626591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?
    Ko E; Chehade M
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):205-216. PubMed ID: 29372536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
    Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
    J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
    Arias Á; Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):99-117. PubMed ID: 30791784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amniotic fluid modifies esophageal epithelium differentiation and inflammatory responses.
    Rochman M; Klinger AM; Caldwell JM; Sadovsky Y; Rothenberg ME
    Am J Physiol Gastrointest Liver Physiol; 2024 Nov; 327(5):G629-G639. PubMed ID: 39189791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic Esophagitis: the Potential Role of Biologics in its Treatment.
    Choudhury S; Baker S
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):150-159. PubMed ID: 31175521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic esophagitis: an autoimmune esophageal disorder.
    Malhotra N; Levine J
    Curr Probl Pediatr Adolesc Health Care; 2014 Dec; 44(11):335-40. PubMed ID: 25499460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of Eosinophilic Esophagitis: A Comprehensive Review of the Genetic and Molecular Aspects.
    Ryu S; Lee KH; Tizaoui K; Terrazzino S; Cargnin S; Effenberger M; Shin JI; Kronbichler A
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the Eosinophilic Esophagitis Histologic Scoring System in Distinguishing Active Eosinophilic Esophagitis From Remission and Gastroesophageal Reflux Disease.
    Lin B; Rabinowitz S; Haseeb MA; Gupta R
    Gastroenterology Res; 2021 Aug; 14(4):220-226. PubMed ID: 34527091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.
    Bolton SM; Kagalwalla AF; Arva NC; Wang MY; Amsden K; Melin-Aldana H; Dellon ES; Bryce PJ; Wershil BK; Wechsler JB
    Am J Gastroenterol; 2020 Feb; 115(2):224-233. PubMed ID: 31913192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis.
    Avlas S; Shani G; Rhone N; Itan M; Dolitzky A; Hazut I; Grisaru-Tal S; Gordon Y; Shoda T; Ballaban A; Ben-Baruch NM; Rochman M; Diesendruck Y; Nahary L; Bitton A; Halpern Z; Benhar I; Varol C; Rothenberg ME; Munitz A
    Allergy; 2023 Feb; 78(2):464-476. PubMed ID: 36070083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current state of biologics in treating eosinophilic esophagitis.
    Nhu QM; Aceves SS
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):15-20. PubMed ID: 36243282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.